197 related articles for article (PubMed ID: 20639691)
1. Is the use of beta-blockers in COPD still an unresolved dilemma?
Foresi A; Cavigioli G; Signorelli G; Pozzoni MB; Olivieri D
Respiration; 2010; 80(3):177-87. PubMed ID: 20639691
[TBL] [Abstract][Full Text] [Related]
2. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
Di Tano G; Frattini S; Pirelli S
G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
[TBL] [Abstract][Full Text] [Related]
3. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
Pescaru C; Tudorache V; Oancea C
Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
[TBL] [Abstract][Full Text] [Related]
4. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.
Egred M; Shaw S; Mohammad B; Waitt P; Rodrigues E
QJM; 2005 Jul; 98(7):493-7. PubMed ID: 15955798
[TBL] [Abstract][Full Text] [Related]
5. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
6. Can beta-blockers be used for people with COPD?
Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
[TBL] [Abstract][Full Text] [Related]
7. [Beta-blockers usage in cardio-vascular diseases co-existing with COPD].
Walczak D; Kowal A; Jankowska R
Pol Merkur Lekarski; 2012 Dec; 33(198):338-41. PubMed ID: 23437704
[TBL] [Abstract][Full Text] [Related]
8. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities of chronic obstructive pulmonary disease.
Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
[TBL] [Abstract][Full Text] [Related]
10. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
Rutten FH
Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
[TBL] [Abstract][Full Text] [Related]
11. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
12. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
[TBL] [Abstract][Full Text] [Related]
14. Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas.
Chhabra SK; Gupta M
Indian J Chest Dis Allied Sci; 2010; 52(4):225-38. PubMed ID: 21302600
[TBL] [Abstract][Full Text] [Related]
15. [Cardiovascular comorbidity in COPD].
Cataluña JJ; García MA
Arch Bronconeumol; 2009; 45 Suppl 4():18-23. PubMed ID: 20116745
[TBL] [Abstract][Full Text] [Related]
16. [Heart failure: critical patients].
Fabbri G; Gorini M; Maggioni AP; Oliva F;
G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
[TBL] [Abstract][Full Text] [Related]
17. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
Bułdak Ł; Duława A; Krysiak R; Okopień B
Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
19. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
[TBL] [Abstract][Full Text] [Related]
20. [Beta-blocker prescription and chronic obstructive pulmonary disease].
Ollivier R; Donal E; Delaval P; Daubert JC; Mabo P
Ann Cardiol Angeiol (Paris); 2007 Nov; 56(5):231-6. PubMed ID: 17854758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
